The fight now unfolding over the Trump administration’s sudden limit on National Institutes of Health grant funding could have deep financial implications for Washington state’s top research institutions. Those impacted… Read More
When Luca Foschini, head of Seattle’s Sage Bionetworks, described the impact of the Trump administration’s efforts to freeze federal grants this week, it sounded like a run on the banks… Read More
Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest funding rounds for a Seattle-area startup in recent years. Tune… Read More
Sonoma Biotherapeutics on Wednesday announced that it received a $45 million payment from Regeneron Pharmaceuticals for meeting a significant milestone in its efforts to research, develop and commercialize therapies for… Read More
The Mars Society says it’s making progress on launching a startup incubator in the Seattle area, with artificial intelligence and biotech as its first targets. Its long-term goal? To make… Read More
Outpace Bio, a Seattle startup using artificial intelligence to design proteins that are incorporated into cancer therapies targeting solid tumors, has raised $144 million in new cash from investors. The… Read More
Seattle’s Aurion Biotech announced Wednesday that it received special designations from the U.S. Food and Drug Administration that should speed up the development of its treatment for a common disease… Read More
Satya Singh, a Seattle-area technology and startup leader who was previously a data platform executive at Expedia, co-founded Scispot, a data infrastructure platform for biotech companies. He recently shared his story… Read More
A-Alpha Bio will receive $14.5 million from the Department of Defense (DOD) to expand a project with a national lab to help prepare for future biological threats using the company’s… Read More
A new test for the early detection of Alzheimer’s Disease — potentially even before symptoms are present — show that the diagnostic caught the neurodegenerative disease in 100% of the… Read More
The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator, has sold its cell therapy platform assets to the Boston… Read More
Sonoma Biotherapeutics on Monday hosted a ribbon cutting ceremony at its new research and development center and office space on Seattle’s waterfront. The biotech company, which has a second location… Read More
Seattle biotech startup Phase Genomics is receiving $1.5 million from the Bill & Melinda Gates Foundation to fund research into two important areas: killing drug-resistant bacteria and battling methane-producing microorganisms… Read More
Pharma giant Pfizer, fresh off its $43 billion acquisition of Seagen, said it will shut down construction on a new 270,000 square-foot manufacturing facility Seagen was building north of Seattle… Read More
Healionics, a Seattle-based medical technology company, raised $5.5 million in new financing aimed at helping the company complete an ongoing human trial and pursue regulatory clearance and commercialization of its… Read More
Biotech giant AstraZeneca has completed its $1.1 billion acquisition of Icosavax, a Seattle-based spinout from the University of Washington’s Institute for Protein Design.
Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The deal will close on Thursday. Seagen is the largest biotech… Read More
There are lots of tasks in biomedicine that are more accurately and efficiently accomplished by a computer than a person — take the detection of breast cancer from a mammogram,… Read More
A group of 20 early-stage life sciences startups in Washington each received $25,000 grants, part of an effort to fuel the “next generation” of life science innovation in the state.… Read More
Seattle biotech startup A-Alpha Bio raised $22.4 million to boost development of its machine learning platform that analyzes protein-protein interactions. A-Alpha Bio, a spinout of the Institute for Protein Design… Read More
Affini-T Therapeutics, a cell therapy company spun out of Fred Hutchinson Cancer Research Center that aims to treat solid tumors, is closing its Seattle lab.
Swiss biopharma giant Novartis announced Monday it plans to buy Seattle-based Chinook Therapeutics for $3.2 billion, marking another blockbuster acquisition for the biotech industry in the Seattle region. Founded in… Read More
Seattle biotech startup Immusoft has received approval to begin clinical trials of its novel strategy for treating genetic disease, the company announced Thursday. Immusoft says it’s the first to get… Read More
Tech startups in Seattle and the Pacific Northwest raised less than $4 billion in funding in the first half of 2022, down 20% from more than $5 billion in the… Read More
Biotech is coming off an epic few years. The sector soared during the pandemic, with venture capital investment and IPO volumes hitting all-time highs. But recently stock valuations have plummeted,… Read More
Hans Bishop and Steve Harr know a few things about biotech. The pair once worked together at Seattle flagship cell therapy company Juno Therapeutics, where Bishop was CEO and Harr… Read More
Absci, the Vancouver, Wash.-based biotech that provides drug and drug target discovery services to other companies, has opened a lab in New York City. The company announced the opening of… Read More
Leen Kawas, the Seattle biotech exec who resigned as CEO of Athira Pharma after an investigation found she had altered doctoral research images that helped to form the initial basis… Read More
Kenneth Galbraith is shaking up Zymeworks within a week of becoming CEO of the Seattle and Vancouver, B.C.-based biotech company. He announced major leadership changes in a statement Wednesday, and… Read More
